Literature DB >> 31578997

Pazopanib for progressive desmoid tumours: children, persistant effects, and cost.

Yoshihiro Nishida1, Tomohisa Sakai2, Hiroshi Koike2, Kan Ito2.   

Abstract

Entities:  

Year:  2019        PMID： 31578997     DOI： 10.1016/S1470-2045(19)30543-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Misdiagnosed desmoid fibromatosis of the chest wall presenting in emergency like as recurrence of post-traumatic hematoma: A case report and review of the literature.

Authors:  Giuseppe Evola; Mario Scravaglieri; Enrico Piazzese; Francesco Roberto Evola; Giovanni Francesco Di Fede; Luigi Piazza
Journal:  Int J Surg Case Rep       Date:  2022-04-04

Review 2.  Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis.

Authors:  Monika Sparber-Sauer; Daniel Orbach; Fariba Navid; Simone Hettmer; Stephen Skapek; Nadège Corradini; Michela Casanova; Aaron Weiss; Matthias Schwab; Andrea Ferrari
Journal:  Br J Cancer       Date:  2021-03-15       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.